Skip Navigation

A Phase III Study of the Hepcidin Mimetic Rusfertide PTG-300 in Patients with Polycythemia Vera

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT05210790

Study #:
STUDY00148851

Start Date:
Sep 29, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05210790

View Complete Trial Details & Eligibility at ClinicalTrials.gov